Featured News
AIM Blog
Recognizing AIM’s October Advocate of the Month: Michelle Alonso
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Critical Alzheimer’s and Dementia Priorities Signed Into Law
Washington, D.C., December 29, 2022 – The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the...
Press Release
Congress Prioritizes Addressing Alzheimer’s and Dementia
Key provisions of the ENACT Act, language to strengthen FDA accelerated approval pathway, a $226 million increase for Alzheimer’s and...
Press Release
Alzheimer’s Association Calls on CMS to Reverse Its Decision to Severely Limit Access to FDA-Approved Alzheimer’s Disease Treatments
Association Files Formal Request for Reconsideration of National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of...
AIM Blog
Alzheimer’s Association Hosts Inaugural State Dementia Services Coordinator Summit
At the end of October, the Alzheimer’s Association hosted the inaugural State Dementia Services Coordinator (DSC) Summit in Washington, D.C...
Press Release
Alzheimer’s Association Statement On Gantenerumab Phase 3 Topline Data Release
Chicago, November 14, 2022 — The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech...
Press Release
Alzheimer’s Impact Movement Names Dr. Joanne Pike its Next President and Chief Executive Officer
Washington, D.C., October 26, 2022 – Joanne Pike, DrPH, current president of the Alzheimer’s Association, will become the president and...